Skip to content

The effect of betamethasone injection in pregnant women exposed to preterm labor

The effect of betamethasone injection on maternal and neonatal outcomes in pregnant women with gestational age 34-37 weeks exposed to preterm labor in Sayyad Shirazi Hospital, Gorgan.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191202045571N1
Enrollment
110
Registered
2020-07-17
Start date
2019-12-22
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm labor.

Interventions

Intervention 1: Intervention group: Group A (Betamethasone Intervention)Intervention Betamethasone 12 mg(Iran Hormone production) intramuscular injection , 2 doses ,Daily. Intervention 2: Control g

Sponsors

Gorgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Gestational age 34-37 weeks, Preterm labor symptoms between the ages of 34-37 weeks gestation Need for prenatal corticosteroid injection according to specialist's diagnosis Consent to participate in the study

Exclusion criteria

Exclusion criteria: Cases of intrauterine growth retardation (IUGR) Congenital malformations Multiple pregnancies Placenta previa Maternal systemic diseases (diabetes, Cardiovascular and endocrine disease ) Receiving two doses of betamethasone before study

Design outcomes

Primary

MeasureTime frame
Incidence of diabetes and hyperglycemia in mothers. Timepoint: FBS and 2Hpp check 6 weeks after delivery for mothers and for infants up to one week later. Method of measurement: Laboratory measurements of FBS and 2Hpp.;Incidence of respiratory distress syndrome in neonates. Timepoint: Neonatal Respiratory Distress Syndrome. Method of measurement: based on neonates clinical manifestation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFakhere Taheri

Gorgan University of Medical Sciences

fakhere21@yahoo.com+98 17 3220 2565

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026